METTL3 and breast cancer: To assess the impact of METTL3-mediated pri-miR-221-3p maturation on ADR resistance in vivo, we generated xenograft models of BC in nude mice by subcutaneously injecting MCF-7/ADR cells stably expressing METTL3 and/or miR-221-3p inhibitor.